Literature DB >> 19319661

Creatine transporter deficiency in two adult patients with static encephalopathy.

A Sempere1, C Fons, A Arias, P Rodríguez-Pombo, R Colomer, B Merinero, P Alcaide, A Capdevila, A Ribes, R Artuch, J Campistol.   

Abstract

Creatine transporter deficiency is a recently identified X-linked inborn error of metabolism. The natural course of the disease is not well delineated since clinical data from adult patients have scarcely been reported. A progressive course of the disease has been noted in a few described cases. We report the first two Spanish adult patients with creatine transporter deficiency and compare their clinical phenotype and the evolution of the disease with those of other published cases. The two brothers were identified in a study of a cohort of 610 mentally handicapped male patients. The disease was detected by biochemical studies and confirmed by DNA studies. The most significant clinical features were mental retardation, epilepsy and autistic behaviour, and these symptoms did not worsen, in contrast to other reports. They did not present gastrointestinal problems or movement disorders. Creatine transporter deficiency could be an underdiagnosed metabolic disorder and should be considered in adult patients with mental retardation. Clinical presentation of this disorder showed marked differences among adult patients and the course of the disease was static in our cases. Detection of additional adult patients might allow better understanding of the phenotypic outcome at a later age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319661     DOI: 10.1007/s10545-009-1083-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  20 in total

1.  High frequency of creatine deficiency syndromes in patients with unexplained mental retardation.

Authors:  L Lion-François; D Cheillan; G Pitelet; C Acquaviva-Bourdain; G Bussy; F Cotton; L Guibaud; D Gérard; C Rivier; C Vianey-Saban; C Jakobs; G S Salomons; V des Portes
Journal:  Neurology       Date:  2006-11-14       Impact factor: 9.910

2.  X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.

Authors:  G S Salomons; S J van Dooren; N M Verhoeven; K M Cecil; W S Ball; T J Degrauw; C Jakobs
Journal:  Am J Hum Genet       Date:  2001-04-20       Impact factor: 11.025

3.  Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening.

Authors:  Angela Arias; Marc Corbella; Carmen Fons; Angela Sempere; Judit García-Villoria; Aida Ormazabal; Pilar Poo; Mercé Pineda; María Antonia Vilaseca; Jaume Campistol; Paz Briones; Teresa Pàmpols; Gajja S Salomons; Antonia Ribes; Rafael Artuch
Journal:  Clin Biochem       Date:  2007-08-10       Impact factor: 3.281

4.  X-linked creatine transporter deficiency: clinical description of a patient with a novel SLC6A8 gene mutation.

Authors:  Maria C Schiaffino; Carlo Bellini; Laura Costabello; Ubaldo Caruso; Cornelis Jakobs; Gajja S Salomons; Eugenio Bonioli
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

5.  [Cerebral creatine transporter deficiency: an infradiagnosed neurometabolic disease].

Authors:  J Campistol; A Arias-Dimas; P Poo; M Pineda; M Hoffman; M A Vilaseca; R Artuch; A Ribes
Journal:  Rev Neurol       Date:  2007 Mar 16-31       Impact factor: 0.870

6.  X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism.

Authors:  P Póo-Argüelles; A Arias; M A Vilaseca; A Ribes; R Artuch; A Sans-Fito; A Moreno; C Jakobs; G Salomons
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

7.  Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging.

Authors:  Amy Newmeyer; Kim M Cecil; Mark Schapiro; Joseph F Clark; Ton J Degrauw
Journal:  J Dev Behav Pediatr       Date:  2005-08       Impact factor: 2.225

8.  Severe epilepsy in X-linked creatine transporter defect (CRTR-D).

Authors:  Maria Margherita Mancardi; Ubaldo Caruso; Maria Cristina Schiaffino; Maria Giuseppina Baglietto; Andrea Rossi; Francesca Maria Battaglia; Gajja Sophi Salomons; Cornelis Jakobs; Federico Zara; Edvige Veneselli; Roberto Gaggero
Journal:  Epilepsia       Date:  2007-06       Impact factor: 5.864

9.  High prevalence of SLC6A8 deficiency in X-linked mental retardation.

Authors:  Efraim H Rosenberg; Ligia S Almeida; Tjitske Kleefstra; Rose S deGrauw; Helger G Yntema; Nadia Bahi; Claude Moraine; Hans-Hilger Ropers; Jean-Pierre Fryns; Ton J deGrauw; Cornelis Jakobs; Gajja S Salomons
Journal:  Am J Hum Genet       Date:  2004-05-20       Impact factor: 11.025

10.  Mental retardation and verbal dyspraxia in a new patient with de novo creatine transporter (SLC6A8) mutation.

Authors:  Roberta Battini; Anna Chilosi; Davide Mei; Manuela Casarano; M Grazia Alessandrì; Vincenzo Leuzzi; Giovanni Ferretti; Michela Tosetti; M Cristina Bianchi; Giovanni Cioni
Journal:  Am J Med Genet A       Date:  2007-08-01       Impact factor: 2.802

View more
  8 in total

1.  Treatment outcome of creatine transporter deficiency: international retrospective cohort study.

Authors:  Theodora U J Bruun; Sarah Sidky; Anabela O Bandeira; Francoise-Guillaume Debray; Can Ficicioglu; Jennifer Goldstein; Kairit Joost; Dwight D Koeberl; Diogo Luísa; Marie-Cecile Nassogne; Siobhan O'Sullivan; Katrin Õunap; Andreas Schulze; Lionel van Maldergem; Gajja S Salomons; Saadet Mercimek-Andrews
Journal:  Metab Brain Dis       Date:  2018-02-12       Impact factor: 3.584

2.  Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.

Authors:  Yuko Kurosawa; Ton J Degrauw; Diana M Lindquist; Victor M Blanco; Gail J Pyne-Geithman; Takiko Daikoku; James B Chambers; Stephen C Benoit; Joseph F Clark
Journal:  J Clin Invest       Date:  2012-07-02       Impact factor: 14.808

3.  Study of inborn errors of metabolism in urine from patients with unexplained mental retardation.

Authors:  Angela Sempere; Angela Arias; Guillermo Farré; Judith García-Villoria; Pilar Rodríguez-Pombo; Lurdes R Desviat; Begoña Merinero; Angels García-Cazorla; Maria A Vilaseca; Antonia Ribes; Rafael Artuch; Jaume Campistol
Journal:  J Inherit Metab Dis       Date:  2010-01-05       Impact factor: 4.982

4.  Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms.

Authors:  David Cheillan; Marie Joncquel-Chevalier Curt; Gilbert Briand; Gajja S Salomons; Karine Mention-Mulliez; Dries Dobbelaere; Jean-Marie Cuisset; Laurence Lion-François; Vincent Des Portes; Allel Chabli; Vassili Valayannopoulos; Jean-François Benoist; Jean-Marc Pinard; Gilles Simard; Olivier Douay; Kumaran Deiva; Alexandra Afenjar; Delphine Héron; François Rivier; Brigitte Chabrol; Fabienne Prieur; François Cartault; Gaëlle Pitelet; Alice Goldenberg; Soumeya Bekri; Marion Gerard; Richard Delorme; Marc Tardieu; Nicole Porchet; Christine Vianey-Saban; Joseph Vamecq
Journal:  Orphanet J Rare Dis       Date:  2012-12-13       Impact factor: 4.123

5.  Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency.

Authors:  Matthew R Skelton; Tori L Schaefer; Devon L Graham; Ton J Degrauw; Joseph F Clark; Michael T Williams; Charles V Vorhees
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

6.  Treatment experience in two adults with creatinfe transporter deficiency.

Authors:  Jack Schjelderup; Sigrun Hope; Christian Vatshelle; Clara D M van Karnebeek
Journal:  Mol Genet Metab Rep       Date:  2021-02-22

7.  SLC6A8 Knockdown Suppresses the Invasion and Migration of Human Hepatocellular Carcinoma Huh-7 and Hep3B Cells.

Authors:  Lu Yuan; Xian Jian Wu; Wen Chuan Li; Chenyi Zhuo; ZuoMing Xu; Chuan Tan; RiHai Ma; JianChu Wang; Jian Pu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 8.  The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.

Authors:  Clemens V Farr; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Front Synaptic Neurosci       Date:  2020-10-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.